nasdaq-compliance

23andMe

When DNA Meets Drama: 23andMe's Board Bows Out!

Talk about a genetic shake-up! 23andMe's entire independent board just resigned, leaving CEO Anne Wojcicki scrambling to find a new team. What happened?

See more